Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Jul 29
 +14.08 / +3.43%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 477.00, with a high estimate of 668.00 and a low estimate of 325.00. The median estimate represents a +12.20% increase from the last price of 425.12.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.93%
Growthannually -9.59%


Growthquarterly 3.49%
Growthannually 24.41%
Key to the earnings and sales forecast charts.